Correction: Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening

Similar Items

• Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening
  od: Sestini, Stefano, i dr.
  Izdano: (2015)
• MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
  od: Mensah, Mavis, i dr.
  Izdano: (2017)
• Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
  od: Sozzi, Gabriella, i dr.
  Izdano: (2014)
• MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature
  od: Fortunato, Orazio, i dr.
  Izdano: (2016)
• Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations()
  od: Hu, Jiangting, i dr.
  Izdano: (2015)